• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 16 of 100
Johnson & Johnson’s latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion settlement, paid out over 25 years
Finance
Johnson & Johnson’s latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion settlement, paid out over 25 years
By Will DanielMay 1, 2024
AMR is on track to lower global life expectancy by an average 1.8 years by 2035, according to a new report from the Global Leaders Group on Antimicrobial Resistance.
Health
Superbugs could lower your life expectancy by nearly 2 years, report says. What to know about antimicrobial resistance
By Lindsey LeakeApril 25, 2024
A scientist in a lab coat peers into a microscope in a lab.
Newsletters
AI for drug discovery draws a $1 billion launch—and a lot of hope
By Sage LazzaroApril 25, 2024
Bill Anderson, chief executive officer of Bayer
Leadership
Pharmaceutical giant Bayer’s manager cull will likely affect thousands of bosses—and the aspirin inventor thinks it will help its ‘brilliant’ Gen Z grads to thrive
By Orianna Rosa RoyleApril 24, 2024
How Moderna’s CIO helps steer the drugmaker’s post-COVID evolution
Newsletters
How Moderna’s CIO helps steer the drugmaker’s post-COVID evolution
By John KellApril 17, 2024
Bill Anderson, chief executive officer of Bayer
Leadership
Pharmaceutical giant Bayer is getting rid of bosses and asking nearly 100,000 workers to ‘self-organize’ to save $2.15 billion
By Orianna Rosa RoyleApril 11, 2024
Pascal Soriot, chief executive officer of Astrazeneca Plc, arrives at the CEO council at the Great Hall of the People in Beijing, Chin
Success
Major investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO
By Ryan HoggApril 10, 2024
Many cancer drugs remain unproven 5 years after accelerated approval, a study finds
Health
Many cancer drugs remain unproven 5 years after accelerated approval, a study finds
By Carla K. Johnson and The Associated PressApril 8, 2024
ALS drug will be pulled from US market after study showed patients didn’t benefit
Health
ALS drug will be pulled from US market after study showed patients didn’t benefit
By Matthew Perrone and The Associated PressApril 4, 2024
It’s time for facts in the PBM debate
Commentary
It’s time for facts in the PBM debate
By David JoynerApril 3, 2024
photo portrait of a middle aged man wearing a suit and tie
Newsletters
Johnson & Johnson CIO says employee upskilling is key to transforming health care
By John KellApril 3, 2024
Pharmacies
Health
‘This is an emergency’: Trade group warns nearly a third of all independent pharmacies will go extinct because of a CMS rule
By Maia Anderson, Healthcare Brew and Morning BrewMarch 30, 2024
An out-of-focus person is point to their left and is standing in front of a window with the red and white Walgreens 'W' on it.
Retail
Walgreens’ frail quarter goes beyond the discretionary spending dips afflicting its competitors. It’s ‘just not very good at retailing,’ analyst says
By Sasha RogelbergMarch 29, 2024
The economics of antibiotics are broken and superbugs are on the rise–but a solution inspired by the subscription economy could save millions of lives
Commentary
The economics of antibiotics are broken and superbugs are on the rise–but a solution inspired by the subscription economy could save millions of lives
By Howard DeanMarch 28, 2024
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
Health
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
By Madison Muller, Robert Langreth and BloombergMarch 28, 2024
1...
  • 14
  • 15
  • 16
  • 17
  • 18
...100
Most Popular
Arts & Entertainment
Ed Sheeran asked Patriots owner Robert Kraft for $2 million aid donation after Macklemore was dropped from his tour for pro-Palestine commentsplaceholder alt text
By Marco Quiroz-GutierrezSeptember 18, 2026
C-Suite
Meet Warren Buffett's son Howard, a former sheriff, war photographer, and now, Berkshire's new chairmanplaceholder alt text
By Catherina GioinoSeptember 18, 2026
Crypto
Sydney Sweeney doesn’t just star in controversial ads. She helps engineer themplaceholder alt text
By Camila Grigera NaónSeptember 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.